Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for:

INDIA-DRUGS/ANALYSIS
RTR2ZA0X
March 13, 2012
A pharmacologist checks the reaction on a nude mouse after applying the SNB cytotoxic drugs for anti-tumour...
Hyderabad, India
A pharmacologist checks the reaction on a nude mouse after applying the SNB cytotoxic drugs for anti-tumour...
A pharmacologist checks the reaction on a nude mouse after applying the SNB cytotoxic drugs for anti-tumour cancer inside the bio safety cabinet at Natco Research Centre in the southern Indian city of Hyderabad March 13, 2012. India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug cheaply in India. REUTERS/Krishnendu Halder (INDIA - Tags: HEALTH ANIMALS)
Sort by
Display
Items per page
Page
of 1